FIELD: medicine. SUBSTANCE: pharmaceutical solution has compound of the general formula (1 mg), surface-active substance taken from the group polyhydroxyethylene hydrogenated castor oil, ester of fatty acid and glycerol, polyethylene glycol, polyhydroxyethylene sorbitol (1-100 mg) and solvent taken from the group: ethanol, propylene glycol, polyethylene glycol and glycerol (0.02-10 ml). EFFECT: enhanced effectiveness of solution. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
IMMUNOSUPPRESSIVE COMPOSITION AND A METHOD OF ITS SYNTHESIS | 1991 |
|
RU2084222C1 |
PHARMACEUTICAL COMPOSITION SHOWING IMMUNOSUPPRESSIVE AND ANTIMICROBIAL ACTIVITIES | 1991 |
|
RU2079304C1 |
MEDICINAL COMPOSITIONS | 1997 |
|
RU2197226C2 |
MEDICINAL AGENT AS OINTMENT FOR CUTANEOUS DISEASE AND CUTANEOUS MANIFESTATION OF IMMUNOLOGICALLY MEDIATED DISEASE TREATMENT AND/OR PROPHYLAXIS AND METHOD OF ITS SYNTHESIS | 1991 |
|
RU2079303C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2043365C1 |
DERIVATIVES OF TRIFLUOROMETHYLKETONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2073684C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DISEASE TREATMENT INTERMEDIARY AGENT OF THAT IS TACHIKININ | 1991 |
|
RU2073683C1 |
ANTIALLERGIC PHARMACEUTICAL COMPOSITION FOR LOCAL OCULAR APPLICATION AND METHOD FOR ITS PRODUCTION | 1994 |
|
RU2107497C1 |
WS-7622A DISULFATES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2087482C1 |
METHOD FOR PRODUCTION OF COMPOUNDS WS 7622 A, B, C AND/OR D-INHIBITORS OF HUMAN LEUCOCYTEELASTASE OR THEIR PHARMACEUTICALLY AVAILABLE SALTS | 1990 |
|
RU2051174C1 |
Authors
Dates
1995-02-09—Published
1991-02-28—Filed